Not currently recruiting at UCLA
Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at Torrance, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Debika Bhattacharya, MD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Debika Bhattacharya, MD
HS Clinical Professor, Medicine. Authored (or co-authored) 71 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- Sign up for this study
- ID
- NCT05551273
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 48 study participants
- Last Updated